Alzheimer’s disease (AD) therapeutics – 2: Beyond amyloid – Re-defining AD and its causality to discover effective therapeutics-Reference-Cited by-同舟云学术

Alzheimer’s disease (AD) therapeutics – 2: Beyond amyloid – Re-defining AD and its causality to discover effective therapeutics

Published:2018-12 Issue: Volume:158 Page:376-401
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Mullane Kevin,Williams Michael^ORCID

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference399 articles.

1. Alzheimer’s Disease therapeutics – 1: Repeated clinical failures question the amyloid hypothesis of AD and the current understanding of disease causality;Mullane;Biochem. Pharmacol.,2018

2. Alzheimer’s disease: a conceptual history;Berrios;Inter. J. Geriatric Psychiatr.,1990

3. The importance of tau phosphorylation for neurodegenerative diseases;Noble;Front. Neurol.,2013

4. Therapeutic strategies for the treatment of tauopathies: hopes and challenges;Khanna;Alzheimer’s Dement.,2016

5. Phospho-tau bar code: analysis of phosphoisotypes of tau and its application to tauopathy;Kimura;Front. Neurosci.,2018

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-functional Ligands and Molecular Hybridization: Conceptual Aspects and Application in the Innovative Design of Drug Candidate Prototypes for Neurodegenerative Diseases;Frontiers in Clinical Drug Research - CNS and Neurological Disorders;2023-04-26

2. Neuroprotective Effects of Vapreotide on Tau Transfection–Induced Neurodegeneration;Neurotoxicity Research;2022-11-15

3. Cerebral Organoids for Modeling of HSV-1-Induced-Amyloid β Associated Neuropathology and Phenotypic Rescue;International Journal of Molecular Sciences;2022-05-26

4. Cerebral organoids for modeling of HSV-1-induced-multiscale neuropathology associated with Alzheimer’s disease and phenotypic rescue;2022-02-13

5. Gardenia jasminoides J.Ellis extract GJ-4 alleviated cognitive deficits of APP/PS1 transgenic mice;Phytomedicine;2021-12